Cocrystal Pharma
COCP
13 hedge funds and large institutions have $1.09M invested in Cocrystal Pharma in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.06% more ownership
Funds ownership: 0% → 0.06% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EU
Emory University
Atlanta,
Georgia
|
+$795K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$66.2K |
| 3 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$43.3K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$20.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EU
1
Emory University
Atlanta,
Georgia
| $910K | +$795K | +12,743 | New |
|
|
BRWA
2
B. Riley Wealth Advisors
Boca Raton,
Florida
| $76K | +$66.2K | +1,061 | New |
|
|
3
Fifth Third Bancorp
Cincinnati,
Ohio
| $50K | +$43.3K | +694 | New |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $24K | +$20.8K | +333 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $15K | +$13.5K | +217 | New |
|
6
Citigroup
New York
| $9K | +$7.74K | +124 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $4K | +$3.5K | +56 | New |
|
|
CA
8
Centerpoint Advisors
Needham,
Massachusetts
| $3K | +$2.62K | +42 | New |
|
|
HCM
9
Highlander Capital Management
Short Hills,
New Jersey
| $2K | +$1.75K | +28 | New |
|
10
ClearBridge Investments
New York
| $1K | +$874 | +14 | New |
|
|
MOS
11
MGO One Seven
Beachwood,
Ohio
| $1K | +$1.06K | +17 | New |
|
12
Morgan Stanley
New York
| – | +$187 | +3 | New |
|
|
EA
13
Edge Advisors
Atlanta,
Georgia
| – | +$874 | +14 | New |
|
COCP Hedge Fund Activity: Q1 2018 in Review
13 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q1 2018, worth a combined $1.09M.
Buyers outnumbered sellers: 13 funds opened new COCP positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Emory University, opening a new position worth an estimated $795K.
- 13 institutional investors held Cocrystal Pharma (COCP) as of Q1 2018, up from 0 in Q4 2017.
- Funds reported $1.09M of Cocrystal Pharma stock for Q1 2018.
- 13 funds opened new Cocrystal Pharma positions in Q1 2018 and 0 closed out, a net change of +13 holders.
- The largest Cocrystal Pharma buyer in Q1 2018 was Emory University, an estimated $795K added.
Based on aggregated 13F filings for Q1 2018.